The Journal of Korean Obstetrics and Gynecology (대한한방부인과학회지)

The Society of Korean Medicine Obstetrics and Gynecology (대한한방부인과학회)
권호 표지
DOI QR코드

DOI QR Code

Intravaginal Administration of Oriental Medicine on Vaginal Atrophy in Menopause : A Systemic Review

폐경기 질 위축에 대한 한약제제 질 내 투여의 효과 : 체계적 문헌 고찰

  • Lee, Soo-Hyung (Dept. of OB & GY, College of Korean Medicine, Wonkwang University) ;
  • Jung, Hyun-Tae (Dept. of OB & GY, College of Korean Medicine, Wonkwang University) ;
  • Kim, Song-Baek (Dept. of OB & GY, College of Korean Medicine, Wonkwang University)
  • 이수형 (원광대학교 한의과대학 부인과학교실) ;
  • 정현태 (원광대학교 한의과대학 부인과학교실) ;
  • 김송백 (원광대학교 한의과대학 부인과학교실)
  • Received : 2021.04.15
  • Accepted : 2021.05.28
  • Published : 2021.05.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study is to review clinical studies and evaluate effectiveness of intravaginal administration of oriental medicine on vaginal atrophy in menopausal women. Methods: 'postmenopause', 'menopause', 'vaginal atrophy', 'atrophic vaginitis', 'vaginal cream', 'vaginal gel', 'pessary', 'suppository' were searched on 3 online databases (Pubmed, Cochrane Library, OASIS). The risk of bias was assessed by using Cochrane risk of bias (RoB) 2.0 tool. Results: 9 randominized controlled trials (RCTs) were selected among 489 articles. The types of intervention were intravaginal administration of oriental medicine. 6 studies showed that treatment group was better than placebo control group or both treatment group and western medicine control group improved similarly. 2 studies were not significant effective in some results and 1 study was not statistically significant. Conclusions: Intravaginal administration of oriental medicine can be an effective option in treating menopausal women with vaginal atrophy. but considering the small number and low quality of studies, further well-designed studies are needed to confirm the effectiveness of this treatment.

Keywords

References

  1. The Society of Korean Medicine Obstetrics and Gynecology. Korean Obstetrics & Gynecology (vol. 2) 1st rev. ed. Seoul: Euiseongdang. 2012:265-7, 276, 285.
  2. Korean Society of Obstetrics and Gynecology. Gynecology. 6th rev. ed. Paju:Koonja. 2021:641-2, 647.
  3. Stephanie S, et al. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause: The Journal of The North American Menopause Society. 2020;27(9):976-92. https://doi.org/10.1097/gme.0000000000001609
  4. Heo SJ, et al. A Study on Urinary Incontinence, Interstitial Cystitis, Atrophic Viginitis of Elderly Women Using Senior Welfare Center and Nursing Home and the Cognition of Traditional Korean Medicine. The Journal of Korean Medicine Obstetrics & Gynecology. 2010;23(3):123-38.
  5. Kang NH, et al. The Clinical Study on 2 Cases of Atrophic Vaginitis in Menopausal Women. The Journal of Korean Medicine Obstetrics & Gynecology. 2016;29(4):34-45. https://doi.org/10.15204/jkobgy.2016.29.4.034
  6. Kim YD, Yu DY. Study on the Treatment in Pruritis Vulva among External Treatment. The Journal of Korean Medicine Obstetrics & Gynecology. 1998;11(2):107-20.
  7. Korea Institute of Oriental Medicine. Defining Dictionary for Medicinal Herbs [Korean, 'Hanyak Giwon Sajeon'] (2021) [cited April 15, 2021]. Available from: URL:https://oasis.kiom.re.kr/herblib/hminfo/hbmcod/hbmcodList.do.
  8. Sadeghi M, et al. Impact of Glycyrrhiza glabra (licorice) vaginal cream on vaginal signs and symptoms of vaginal atrophy in postmenopausal women: A randomized double blind controlled trial. Journal of Traditional and Complementary Medicine. 2020;10(2):110-5. https://doi.org/10.1016/j.jtcme.2019.02.005
  9. Poordast T, et al. Aloe Vera; A new treatment for atrophic vaginitis, A randomized double-blinded controlled trial. Journal of Ethnopharmacology. 2021;270(1):1-6(113760).
  10. Lima SM, et al. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas. 2013;74(3): 252-8. https://doi.org/10.1016/j.maturitas.2012.11.012
  11. Lima SM, et al. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled trial. Maturitas. 2014;78(3):205-11. https://doi.org/10.1016/j.maturitas.2014.04.007
  12. Lima SM, Honorato J, Silva MA. Glycine Max (L.) Merr isoflavone gel improves vaginal vascularization in postmenopausal women. Climacteric. 2020;23(5):505-10. https://doi.org/10.1080/13697137.2020.1752172
  13. Bosak Z, et al. Evaluation of the influence of chamomile vaginal gel on dyspareunia and sexual satisfaction in postmenopausal women: A randomized, double-blind, controlled clinical trial. Avicenna Journal of Phytomed. 2020; 10(5):481-91.
  14. Seyyedi F, Kopaei MR, Miraj S. Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study. Electron Physician. 2016; 8(11):3184-92. https://doi.org/10.19082/3184
  15. Safary M, et al. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low-Dose Estrogen on Atrophic Vaginitis. Current Drug Delivery. 2020;17(9):815-22. https://doi.org/10.2174/1567201817666200708112655
  16. Yaralizadeh M, et al. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial. Maturitas. 2016;84(1):75-80. https://doi.org/10.1016/j.maturitas.2015.11.005
  17. Sterne JAC, et al. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). 2019;1-72. [cited April 15, 2021]. Available from:URL:https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2
  18. Evidence Synthesis Hackathon. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments [cited April 15, 2021]. Available from:URL:https://mcguinlu.shinyapps.io/robvis/.
  19. Morali G, et al. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung. 2006;56(3):230-8. https://doi.org/10.1055/s-0031-1296715
  20. Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33. https://doi.org/10.1001/jama.288.3.321
  21. Anderson GL, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-12. https://doi.org/10.1001/jama.291.14.1701
  22. Chlebowski RT, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA. 2020;324(4):369-80. https://doi.org/10.1001/jama.2020.9482
  23. Park EJ, Jo HG. Application of Traditional East Asian Herbal Medicine for Atrophic Vaginitis: A Systematic Review of Randomized Controlled Trials. The Journal of Korean Medicine Obstetrics & Gynecology. 2019;32(3):227-44.
  24. Krizova L, et al. Isoflavones. Molecules. 2019;24(6):1-28(1076).
  25. Balan A, et al. Royal Jelly-A Traditional and Natural Remedy for Postmenopausal Symptoms and Aging-Related Pathologies. Molecules. 2020;25(14):1-22(3291).
  26. Weber MA, Limpens J, Roovers JPWR. Assessment of vaginal atrophy: a review. International Urogynecology Journal. 2015;26(1):15-28. https://doi.org/10.1007/s00192-014-2464-0